HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ilaria De Stefano Selected Research

Estrogen Receptor beta

1/2012Estrogen receptor beta in cancer: an attractive target for therapy.
9/2011Cytoplasmic expression of estrogen receptor beta (ERĪ²) predicts poor clinical outcome in advanced serous ovarian cancer.
7/2008Soy phytochemicals decrease nonsmall cell lung cancer growth in female athymic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ilaria De Stefano Research Topics

Disease

12Neoplasms (Cancer)
11/2017 - 06/2007
4Carcinogenesis
11/2017 - 01/2012
4Ovarian Neoplasms (Ovarian Cancer)
01/2013 - 07/2011
3Medulloblastoma
10/2016 - 12/2010
2Residual Neoplasm
11/2017 - 02/2012
2Brain Neoplasms (Brain Tumor)
10/2016 - 11/2013
1Radiation Injuries (Radiation Sickness)
02/2022
1Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2017
1Genomic Instability
11/2017
1Cataract (Cataracts)
01/2015
1Endometrial Neoplasms (Endometrial Cancer)
06/2013
1Carcinoma (Carcinomatosis)
11/2012
1Neoplasm Metastasis (Metastasis)
02/2012
1Ascites
07/2011
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2011
1Skin Neoplasms (Skin Cancer)
12/2009
1Experimental Melanoma
12/2009
1Melanoma (Melanoma, Malignant)
12/2009
1Lung Neoplasms (Lung Cancer)
07/2008
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2008
1Breast Neoplasms (Breast Cancer)
06/2007

Drug/Important Bio-Agent (IBA)

6Estrogen ReceptorsIBA
01/2014 - 06/2007
5Estrogens (Estrogen)FDA Link
01/2014 - 06/2007
3Progesterone Receptors (Progesterone Receptor)IBA
06/2013 - 09/2011
3Estrogen Receptor betaIBA
01/2012 - 07/2008
2MicroRNAs (MicroRNA)IBA
02/2022 - 10/2016
2Transcription Factors (Transcription Factor)IBA
01/2015 - 01/2013
2Proteins (Proteins, Gene)FDA Link
01/2014 - 01/2013
2Estradiol (Delestrogen)FDA LinkGeneric
12/2010 - 06/2007
2Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
12/2009 - 07/2008
2Phytoestrogens (Phytoestrogen)IBA
07/2008 - 06/2007
1EnzymesIBA
11/2017
1prelamin AIBA
11/2017
1LaminsIBA
11/2017
1Biomarkers (Surrogate Marker)IBA
11/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2015
1Phosphopyruvate Hydratase (Enolase)IBA
01/2014
1Glial Fibrillary Acidic ProteinIBA
01/2014
1Cyclin-Dependent Kinase Inhibitor p21IBA
01/2014
1NestinIBA
01/2014
1Connexin 43 (Connexin43)IBA
08/2013
1Indicators and Reagents (Reagents)IBA
06/2013
13- keto- N- aminoethylaminoethylcaproyldihydrocinnamoyl cyclopamineIBA
01/2013
1GANT58IBA
01/2013
1Neoplasm Antigens (Tumor Antigens)IBA
02/2012
1Paclitaxel (Taxol)FDA LinkGeneric
07/2011
1ONCOFID-PIBA
07/2011
1Hyaluronic Acid (Hyaluronan)IBA
07/2011
1Cadherins (E-Cadherin)IBA
01/2011
1Biological FactorsIBA
12/2010
1Mitogen-Activated Protein KinasesIBA
12/2009
1sanguinarineIBA
12/2009
1AlkaloidsIBA
12/2009
1ErbB Receptors (EGF Receptor)IBA
07/2008
1PhytochemicalsIBA
07/2008
1Insulin-Like Growth Factor I (IGF-1)IBA
06/2007
1Pharmaceutical PreparationsIBA
06/2007
1MitogensIBA
06/2007
1Thrombospondin 1IBA
06/2007
1Messenger RNA (mRNA)IBA
06/2007
1Kallikreins (Kallikrein)IBA
06/2007
1IsoflavonesIBA
06/2007

Therapy/Procedure

5Therapeutics
11/2013 - 06/2007
1Neoadjuvant Therapy
11/2017
1Adjuvant Radiotherapy
10/2017